News

Ozempic copies restricted after US judge deni
April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...
9 Best Growth Stocks for the Next 10 Years
Top long-term investments are companies with consistent top-line growth and profitability, as well as scale and a unique business focus with a strong outlook for the next several years. There's no ...
CFO of SAP, Europe’s most valuable company, hopes trade war is a ‘wake-up call’ for the continent
SAP's finance chief, Dominik Asam, hopes tariffs are a "wake-up call" that can kickstart Europe into building more tech giants.
Inflection Points: Roll With The Changes
Nvidia introduced the Blackwell Ultra and Vera Rubin, its most powerful AI chips to date, amid escalating demand for AI ...
The Next Big Theme: April 2025
Nvidia introduced the Blackwell Ultra and Vera Rubin, its most powerful AI chips to date, amid escalating demand for AI ...
Could Novo Nordisk's Wegovy-fuelled run of hiking sales guidance be ending?
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...